Connect with us
Asabys, which counts Alantra as a strategic partner, launched the first fund four years ago with an initial target of €60 million and the support of...
Indukern is a national business group created in 1962. Its activity is focused on human and animal health through its two main companies: Kern Pharma, a...
On an international scale, one of the recent projects in which Ship2B Ventures has invested is Fosanis, a German company specializing in digital health. The Teutonic...
Between 2016 and 2021 the investment in the acquisition of medium and high-tech equipment in Aragonese healthcare has exceeded €43 million. Since that date, two linear...
Among the companies selected by Lanzadera there are projects related to the diagnosis of sepsis, pathologies related to muscles and skeletons or those that investigate skin...
The European Union plans to become an important point for clinical trials. The work plan is structured according to the ten ACT EU priority actions and...
The Swiss pharmaceutical company plans to lay off 8,000 workers worldwide, equivalent to 7.7% of the total workforce. The Novartis job cuts are part of the...
Bioasis Technologies Inc. has recently announced partnerships for its xB3 pharmaceutical platform with Janssen Biotech and Nueramedy, along with the acquisition of Cresence AS' Epidermal Growth...
During the project, two demonstration units will be built for the production of microalgae from these agricultural effluents, one in the Algarve and the second in...
At its latest meeting, held July 28th, REvalMed group has agreed to start work on the Therapeutic Positioning Reports (TPRs) for vutrisiran, voclosporin, tirzepatide, fosdenopterin, relatlimab...
 |
|
 |  |
 |
|